《復牌表現》思捷(00330.HK)續挫29%屢尋底 歐附屬申請財產保護訴訟程序
思捷環球(00330.HK)歐洲附屬申請財產保護訴訟程序,該股今天復牌延續停牌前尋底頹勢,急挫29%報0.54元,創上市新低,成交320萬股。
思捷公布,為保障集團之償付能力和資金流動性及在新冠肺炎疫情期間,集團業務仍能持續運作而作出一項主動性和前瞻性措施,旗下6間附屬已於本月27日根據德國破產法例申請啟動財產保護訴訟程序(旨在有效重組所有債務和長期租賃合同及可從德國聯邦就業局獲得德國員工的薪金和社會保障金資助)。聲明指,由於疫情肆虐,接近所有歐洲國家公眾生活受到全面限制,導致集團在歐洲所有店舖及近所有特許經營及批發合作夥伴可控制銷售點店舖關閉,對集團銷售繼續造成重大負面影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.